Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 2181-2190 of 9364

Page
per page
  1. EGFR Inhibitor
    C3327 EGFR Inhibitor
    Summary: EGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥60.7 mg/mL
  2. DL-α-Difluoromethylornithine (hydrochloride hydrate)
    C3328 DL-α-Difluoromethylornithine (hydrochloride hydrate)
    Summary: ornithine decarboxylase inhibitor, irreversible
      insoluble in DMSO; insoluble in EtOH; ≥11.55 mg/mL
  3. Isoxsuprine (hydrochloride)
    C3347 Isoxsuprine (hydrochloride)
    Summary: β-adrenergic receptor modulator
      insoluble in H2O; insoluble in EtOH; ≥16.3 mg/mL
  4. ML-356
    C3354 ML-356
    Summary: thioesterase domain of fatty acid synthase (FAS-TE) inhibitor
      ≤0.5 mg/mL
  5. S18886
    C5387 S18886
    Summary: Potent thromboxane A2 (TP) inhibitor
      ≤2 mg/mL
  6. SQ 29,548
    C4237 SQ 29,548
    Summary: TP receptor antagonist
      ≤0.9 mg/mL
  7. Latrunculin B
    C5804 Latrunculin B
     1 Citation
    Summary: F-actin–destabilizing agent
      ≤25 mg/mL
  8. I-BOP
    C5805 I-BOP
    Summary: TP specific agonist
      ≤25 mg/mL
  9. 1-Deoxygalactonojirimycin (hydrochloride)
    C3034 1-Deoxygalactonojirimycin (hydrochloride)
    Summary: α-galactosidase inhibitor
      ≤10 mg/mL
  10. Clinafloxacin (hydrochloride)
    C3345 Clinafloxacin (hydrochloride)
    Summary: fluoroquinolone antibiotic that displays broad-spectrum antibacterial activity
      insoluble in DMSO; insoluble in EtOH; ≥13.13 mg/mL

Items 2181-2190 of 9364

Page
per page